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Introduction
Diabetes is defined as a common metabolic
disorder where hyperglycemia or elevated
glucose levels are prevalent (Shah & Vella, 2014).
The most common form of diabetes is type two
diabetes (T2DM) and effects around 9.3% of the
population in the United States (Cornell, 2015, p.
631). The pathophysiology of this disease includes
involvement from the pancreas, liver, skeletal
muscle, adipose tissue, gastrointestinal tract, brain,
and kidneys. Hyperglycemia is high blood sugar
levels that effects multiple organs (Rymaszewski &
Breakwell, 2013). Protocols are developed to allow
nurses to identify and treat hyper/hypoglycemia.
Patient education is a direct impact of the long
term effects of this illness. Maintaining a blood
glucose level of 80-110 for hospitalized patients is
a key component to faster recovery and less
hospital days (Dumont & Bourguignon, 2012).
Obesity is directly related to an increase of diabetes
in the United States. There are many risk factors for
T2DM including age, race, pregnancy, stress,
genetics, and obesity. Obesity leads to a decreased
ability to produce insulin properly and
development of T2DM. Diabetes is largely
preventable by maintaining a healthy weight with
proper diet and exercise.

Underlying
Pathophysiology
Insulin resistance T2DM is directly related to
obesity. Obesity is due to a difference in the amount
of energy used verses the amount of food eaten. The
excessive accumulation of adipose tissue can lead to
obesity and increased inflammation. Adipose tissue
is where energy is stored and released. Energy is in
the form of triglycerides. Adipose sites contain
multiple cell types such as adipocytes,
preadipocytes, endothelial cells, and immune cells.
An excessive amount of fat accumulation promotes
the release of free fatty acids. Hypertrophy or
enlargement of adipocytes are associated with
obesity and play an important role in insulin
resistance. When energy is needed, such as with
exercise, the triglycerides are mobilized by lipolysis
and FFA’s are released. The FFA’s are then
transported to other tissues and used as energy.
FFA’s are a key link to obesity and metabolic
disorders such as insulin resistance T2DM (Jung &
Choi, 2014). FFA’s enter the liver portal, serve as a
ligand-toll receptor, and produce cytokines and
macrophages that cause inflammation.

Pathophysiology of Diabetes

Significance of Pathophysiology

The pathophysiology of Diabetes involves multiple organs. The
pancreas is responsible for the B-cell function and insulin secretion.
People that have impaired glucose tolerance may have lost 80% of
their b-cell function early on in the disease (Cornell, 2015). A decline
in B-cell function is due to elevated glucose levels and free fatty
acids, age, genetics, poor diet and lack of exercise. The liver is the
main organ where glucose is produced. Diabetic patients have an
overproduction of glucose by the liver (Cornell, 2015).).
Overproduction of hepatic glucose comes from gluconeogenesis
and glycogenolysis. Gluconeogenesis is the formation of glucose
from sources other than carbohydrates. The process takes place in
the liver. Glucogenolysis is the process of glycogen forming into
glucose. Glucose is needed for energy and metabolic function. The
muscles aid in disposal of exogenous glucose and transportation of
glucose to the skeletal muscles. Patients with T2DM have a
resistance to the action of insulin in the muscles due to lack of
physical activity. This causes a decrease in the glucose uptake, which
further leads to hyperglycemia. The adipose tissue become resistant
to insulin which leads to an excess amount of free fatty acids (FFA)
in the blood stream. Chronic high levels of FFA’s stimulate
gluconeogenesis. “Brown fat” is a very metabolically active adipose
tissue found in patients with weight control concerns (Cornell, 2015.
Newer research suggest that brown fat may play an important role
in how the body metabolizes glucose and energy production. Insulin
crosses the blood brain barrier and can become resistant over time.
Leptin is a hormone that acts on the hypothalamus by controlling
food intake and energy (Cornell, 2015). Many patients with T2DM
are obese and have high levels of circulating leptin. Amylin is a
peptide that is secreted from B-cells along with insulin. It works to
slow digestive emptying and reduce glucagon release.
Since patients with T2DM have a decrease production of B-cells,
amylin secretion is also decreased. Glucagon-like peptide (GLP-1)
and glucose-dependent insulin tropic polypeptide (GIP) are released
by the gastrointestinal tract and stimulate the release of insulin.
There is a decline in production of GLP-1 and GIP, which results in
hyperglycemic effects. The kidneys work to filter the glucose. When
the glucose levels exceed the renal threshold (180ml/dL) the glucose
is excreted into the urine. Patients with T2DM are able to absorb
glucose by the kidneys and return it to circulate in the body causing
hyperglycemia (Cornell, 2015).

Insulin resistance is a decreased ability for the tissues such as adipose
tissue to react to insulin. Insulin is activated by binding to the cell receptor
causing phosphorylation of the insulin receptor substrate (IRS) proteins that
signal two pathways. These pathways aid in the transport of glucose to the
plasma membrane, resulting in hypertrophic adipose tissue. Obesity produces
extracellular concentrations of lipids and abundance accumulation of
macrophages in adipose tissue which causes insulin resistance. Inflammation,
cytokines and other bioactive substances are linked to obesity induced insulin
resistance. The significant impact of obesity has nearly doubled from 1980 to
2008 (Jung & Choi, 2014). This fast growing concern with obesity related
insulin resistance leads to the development of T2DM along with other health
conditions such as heart disease, stroke, retinopathy, encephalopathy,
neuropathy, and peripheral vascular disease (Jung & Choi, 2014).

Note: adapted from Molecular Link between Obesity and Type 2
Diabetes Reveals Potential Therapy (2015).

Conclusion
There is no cure for T2DM. Physicians, nurse
practitioners, and nurses play a key role in the education
about this disease, including how to prevent and manage
T2DM. Oral medication and insulins are effective
treatment options, but ultimately controlling the glucose
levels by diet and exercise help decrease the severity of the
illness. Diabetes can affect many other organs including
your heart, kidneys, brain, eyes, and vascular system.
Optimal glucose control is achieved by early diagnosis and
intense treatment. Diet and exercise play a key role in
decreasing the risk of developing T2DM. Understanding
how to keep a body mass index below30 kg/m2 will help
with insulin resistance.

Note: adapted from National Institute of diabetes and
digestive and Kidney disease. (2015).
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